Roche announces definitive agreement to acquire Seragon Pharmaceuticals
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
Amgen receives FDA Breakthrough Therapy Designation for investigational BiTE® antibody blinatumomab in acute lymphoblastic leukemia
- Details
- Category: Amgen
![Amgen Amgen](/images/stories/logo/amgen.gif)
Boehringer Ingelheim Statement on Hepatitis C drug development
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](/images/stories/logo/boehringeringelheim.gif)
James C. Smith elected to Pfizer's Board of Directors
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/stories/logo/pfizer_b.gif)
Abbott to acquire Veropharm
- Details
- Category: Abbott
![Abbott Abbott](/images/stories/logo/abbott.gif)
Sanofi and Medtronic to form strategic alliance
- Details
- Category: Sanofi
![Sanofi Sanofi](/images/stories/logo/sanofi.gif)
Roche Children's Walk 2014
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
More Pharma News ...
- Pfizer and Cellectis enter into global strategic cancer immunotherapy collaboration
- Pfizer opens new state-of-the-Art research and development site in Cambridge, Massachusetts
- Mindprint implements market-leading automation solution for Ockham Oncology
- Sanofi and Lilly announce licensing agreement for Cialis® (tadalafil) OTC
- Bristol-Myers Squibb and Syngene International extend research collaboration
- AstraZeneca updates on the rapid progress of its oncology pipeline at ASCO 2014
- Bayer and Orion Corporation to develop and commercialize novel prostate cancer treatment